Loading clinical trials...
Loading clinical trials...
This study is designed to evaluate efficacity and safety of everolimus or (cyclosporine then everolimus) vs. cyclosporine as immunosuppressive treatment in renal transplantation for elderly (\>60 year...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Brest
Collaborators
NCT07531966 · Kidney Transplant Recipient, Kidney Transplant; Complications, and more
NCT05702931 · Hyperglycemia, Renal Transplant Complication Primary Non-Function, and more
NCT07294183 · Renal Transplantation
NCT06406179 · Renal Transplantation
NCT07090512 · Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
CHU Amiens
Amiens
CHU Pellegrin - Bordeaux
Bordeaux
CHRU de BREST
Brest
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions